TERALITHE LP 400 mg, scored tablet with extended release 60 tablets
Active ingredients: Lithium carbonate, Lithium
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Scored tablet with extended release60 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- TERALITHE LP 400 mg, comprimé sécable à libération prolongée
- Pharmaceutical form
- comprimé sécable à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC de 60 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES DELBERT
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1995
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67292476CIP73372736CIP133400933727369Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARBONATE DE LITHIUMcomprimé | 400 mg · un comprimé | SA |
| LITHIUMcomprimé | 10,8 mEq · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.